Publication | Open Access

The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer

Pancreatic CancerLow-dose Adjuvant Gm-csfMedicineImmunologyCapecitabine Combination ChemotherapyImmune Checkpoint InhibitorAdvanced Pancreatic CancerCancer TreatmentOncologyRadiation OncologyCancer Research